Literature DB >> 31586032

The transcription factor PU.1 mediates enhancer-promoter looping that is required for IL-1β eRNA and mRNA transcription in mouse melanoma and macrophage cell lines.

Soon-Duck Ha1, Woohyun Cho1, Rodney P DeKoter1, Sung Ouk Kim2.   

Abstract

The DNA-binding protein PU.1 is a myeloid lineage-determining and pioneering transcription factor due to its ability to bind "closed" genomic sites and maintain "open" chromatin state for myeloid lineage-specific genes. The precise mechanism of PU.1 in cell type-specific programming is yet to be elucidated. The melanoma cell line B16BL6, although it is nonmyeloid lineage, expressed Toll-like receptors and activated the transcription factor NF-κB upon stimulation by the bacterial cell wall component lipopolysaccharide. However, it did not produce cytokines, such as IL-1β mRNA. Ectopic PU.1 expression induced remodeling of a novel distal enhancer (located ∼10 kbp upstream of the IL-1β transcription start site), marked by nucleosome depletion, enhancer-promoter looping, and histone H3 lysine 27 acetylation (H3K27ac). PU.1 induced enhancer-promoter looping and H3K27ac through two distinct PU.1 regions. These PU.1-dependent events were independently required for subsequent signal-dependent and co-dependent events: NF-κB recruitment and further H3K27ac, both of which were required for enhancer RNA (eRNA) transcription. In murine macrophage RAW264.7 cells, these PU.1-dependent events were constitutively established and readily expressed eRNA and subsequently IL-1β mRNA by lipopolysaccharide stimulation. In summary, this study showed a sequence of epigenetic events in programming IL-1β transcription by the distal enhancer priming and eRNA production mediated by PU.1 and the signal-dependent transcription factor NF-κB.
© 2019 Ha et al.

Entities:  

Keywords:  DNA looping; IL-1beta; PU.1; chromatin modification; eRNA; enhancer; gene expression; histone acetylation; interleukin 1 (IL-1); macrophage; melanoma; melanoma cells; transcription factor

Mesh:

Substances:

Year:  2019        PMID: 31586032      PMCID: PMC6873190          DOI: 10.1074/jbc.RA119.010149

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  88 in total

Review 1.  Functional and mechanistic diversity of distal transcription enhancers.

Authors:  Michael Bulger; Mark Groudine
Journal:  Cell       Date:  2011-02-04       Impact factor: 41.582

2.  Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element.

Authors:  J W Pierce; M Lenardo; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex.

Authors:  R Kodandapani; F Pio; C Z Ni; G Piccialli; M Klemsz; S McKercher; R A Maki; K R Ely
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

4.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.

Authors:  E W Scott; M C Simon; J Anastasi; H Singh
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

5.  YY1 Is a Structural Regulator of Enhancer-Promoter Loops.

Authors:  Abraham S Weintraub; Charles H Li; Alicia V Zamudio; Alla A Sigova; Nancy M Hannett; Daniel S Day; Brian J Abraham; Malkiel A Cohen; Behnam Nabet; Dennis L Buckley; Yang Eric Guo; Denes Hnisz; Rudolf Jaenisch; James E Bradner; Nathanael S Gray; Richard A Young
Journal:  Cell       Date:  2017-12-07       Impact factor: 41.582

Review 6.  Enhancer function: new insights into the regulation of tissue-specific gene expression.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  Nat Rev Genet       Date:  2011-03-01       Impact factor: 53.242

Review 7.  Enhancer RNAs and regulated transcriptional programs.

Authors:  Michael T Y Lam; Wenbo Li; Michael G Rosenfeld; Christopher K Glass
Journal:  Trends Biochem Sci       Date:  2014-03-24       Impact factor: 13.807

8.  PU.1 and C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers.

Authors:  Fulai Jin; Yan Li; Bing Ren; Rama Natarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

9.  Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.

Authors:  Minna U Kaikkonen; Nathanael J Spann; Sven Heinz; Casey E Romanoski; Karmel A Allison; Joshua D Stender; Hyun B Chun; David F Tough; Rab K Prinjha; Christopher Benner; Christopher K Glass
Journal:  Mol Cell       Date:  2013-08-08       Impact factor: 17.970

10.  Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B.

Authors:  H M Chen; P Zhang; M T Voso; S Hohaus; D A Gonzalez; C K Glass; D E Zhang; D G Tenen
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

View more
  7 in total

Review 1.  BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs.

Authors:  Patricia Cristine Borck; Lian-Wang Guo; Jorge Plutzky
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 2.  What sequencing technologies can teach us about innate immunity.

Authors:  Mays Mohammed Salih; Susan Carpenter
Journal:  Immunol Rev       Date:  2021-11-07       Impact factor: 12.988

3.  Genomic and epigenomic adaptation in SP-R210 (Myo18A) isoform-deficient macrophages.

Authors:  Eric Yau; Yan Chen; Chunhua Song; Jason Webb; Marykate Carillo; Yuka Imamura Kawasawa; Zhenyuan Tang; Yoshinori Takahashi; Todd M Umstead; Sinisa Dovat; Zissis C Chroneos
Journal:  Immunobiology       Date:  2021-10-25       Impact factor: 3.144

Review 4.  Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects.

Authors:  Lilin Wan; Wenchao Li; Yuan Meng; Yue Hou; Ming Chen; Bin Xu
Journal:  Front Immunol       Date:  2022-04-19       Impact factor: 8.786

Review 5.  The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors.

Authors:  Maciej Sobczak; Marharyta Zyma; Agnieszka Robaszkiewicz
Journal:  Cells       Date:  2020-09-06       Impact factor: 6.600

6.  Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection.

Authors:  Guillermo Barturen; Elena Carnero-Montoro; Manuel Martínez-Bueno; Silvia Rojo-Rello; Beatriz Sobrino; Óscar Porras-Perales; Clara Alcántara-Domínguez; David Bernardo; Marta E Alarcón-Riquelme
Journal:  Nat Commun       Date:  2022-08-06       Impact factor: 17.694

7.  Identification and Functional Characterization of Two Noncoding RNAs Transcribed from Putative Active Enhancers in Hepatocellular Carcinoma.

Authors:  Ye-Eun Lee; Jiyeon Lee; Yong Sun Lee; Jiyoung Joan Jang; Hyeonju Woo; Hae In Choi; Young Gyu Chai; Tae-Kyung Kim; TaeSoo Kim; Lark Kyun Kim; Sun Shim Choi
Journal:  Mol Cells       Date:  2021-09-30       Impact factor: 5.034

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.